Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating

Seong Min Kim, Kwang Sook Park, Eugene Lih, Young Joon Hong, Jong Hee Kang, Ik Hwan Kim, Myung Ho Jeong, Yoon Ki Joung, Dong Keun Han

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Stent implantation with balloon angioplasty is a widely used treatment for coronary artery diseases. Stents have been developed from bare metal stent (BMS) to advanced forms such as drug-eluting stent (DES). However, modern DES still causes thrombosis and/or in-stent restenosis as long-term outcomes. For effective prevention of these problems, we fabricated a dual functionalized stent using spatio-temporal coating, which has two different surfaces, as a novel type of DES. Hyaluronic acid conjugated with dopamine (HA-DA) was applied to a bare cobalt-chromium (CC) stent prior to abluminal coating of sirolimus (SRL)-in-polymer such as poly(d,. l-lactide). The SRL-in-polymer (P+S) coated on the abluminal surface of the HA-DA modified stent showed highly stable coating layer and prevented the crack formation after ballooning. In the blood- and cyto-compatibility tests, HA-DA coating displayed suppressive effects on adhesion and activation of platelets and maintained the cell viability and proliferation of human coronary artery endothelial cells even under the existence of SRL. In in vivo study using porcine restenosis model, the neointimal area and inflammation score of the dual functionalized stent with HA-DA and P+S were significantly reduced than those of BMS. It is expected that this novel type of DES can be effectively applied to utilize diverse anti-proliferative drugs and bioactive polymers. Statement of Significance: Stents have been developed from bare metal stent to advanced forms such as drug-eluting stents (DESs). However, even DESs can still cause in-stent restenosis as long-term outcomes. This paper demonstrated a novel DES using spatio-temporal coating by dopamine-mediated hyaluronic acid coating (HA-DA) before asymmetric coating of sirolimus-in-poly(d,. l-lactide) (P+S). It showed stable coating surface and prevented crack formation after ballooning. HA-DA coating also had an inhibitive effect on adhesion of platelets and maintained cell viability of endothelial cells even under the existence of sirolimus. Additionally, in vivo neointima area and inflammation score of HA-DA/P+S stent significantly decreased than those of BMS. We expected that this novel type of DES can be effectively applied to introduce diverse anti-proliferative drugs and bioactive molecules.

Original languageEnglish
JournalActa Biomaterialia
DOIs
Publication statusAccepted/In press - 2016 Jan 5

Fingerprint

Stents
Blood Vessels
Drug-Eluting Stents
Fabrication
Coatings
Sirolimus
Pharmaceutical Preparations
Metals
Polymers
Hyaluronic Acid
Dopamine
Cell Survival
Hyaluronic acid
Endothelial Cells
Endothelial cells
Inflammation
Platelets
Neointima
Crack initiation
Balloon Angioplasty

Keywords

  • Drug-eluting stent
  • Hyaluronic acid
  • Restenosis
  • Sirolimus
  • Spatio-temporal coating

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating. / Kim, Seong Min; Park, Kwang Sook; Lih, Eugene; Hong, Young Joon; Kang, Jong Hee; Kim, Ik Hwan; Jeong, Myung Ho; Joung, Yoon Ki; Han, Dong Keun.

In: Acta Biomaterialia, 05.01.2016.

Research output: Contribution to journalArticle

Kim, Seong Min ; Park, Kwang Sook ; Lih, Eugene ; Hong, Young Joon ; Kang, Jong Hee ; Kim, Ik Hwan ; Jeong, Myung Ho ; Joung, Yoon Ki ; Han, Dong Keun. / Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating. In: Acta Biomaterialia. 2016.
@article{04a593445798426cb71858a3513c6f9f,
title = "Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating",
abstract = "Stent implantation with balloon angioplasty is a widely used treatment for coronary artery diseases. Stents have been developed from bare metal stent (BMS) to advanced forms such as drug-eluting stent (DES). However, modern DES still causes thrombosis and/or in-stent restenosis as long-term outcomes. For effective prevention of these problems, we fabricated a dual functionalized stent using spatio-temporal coating, which has two different surfaces, as a novel type of DES. Hyaluronic acid conjugated with dopamine (HA-DA) was applied to a bare cobalt-chromium (CC) stent prior to abluminal coating of sirolimus (SRL)-in-polymer such as poly(d,. l-lactide). The SRL-in-polymer (P+S) coated on the abluminal surface of the HA-DA modified stent showed highly stable coating layer and prevented the crack formation after ballooning. In the blood- and cyto-compatibility tests, HA-DA coating displayed suppressive effects on adhesion and activation of platelets and maintained the cell viability and proliferation of human coronary artery endothelial cells even under the existence of SRL. In in vivo study using porcine restenosis model, the neointimal area and inflammation score of the dual functionalized stent with HA-DA and P+S were significantly reduced than those of BMS. It is expected that this novel type of DES can be effectively applied to utilize diverse anti-proliferative drugs and bioactive polymers. Statement of Significance: Stents have been developed from bare metal stent to advanced forms such as drug-eluting stents (DESs). However, even DESs can still cause in-stent restenosis as long-term outcomes. This paper demonstrated a novel DES using spatio-temporal coating by dopamine-mediated hyaluronic acid coating (HA-DA) before asymmetric coating of sirolimus-in-poly(d,. l-lactide) (P+S). It showed stable coating surface and prevented crack formation after ballooning. HA-DA coating also had an inhibitive effect on adhesion of platelets and maintained cell viability of endothelial cells even under the existence of sirolimus. Additionally, in vivo neointima area and inflammation score of HA-DA/P+S stent significantly decreased than those of BMS. We expected that this novel type of DES can be effectively applied to introduce diverse anti-proliferative drugs and bioactive molecules.",
keywords = "Drug-eluting stent, Hyaluronic acid, Restenosis, Sirolimus, Spatio-temporal coating",
author = "Kim, {Seong Min} and Park, {Kwang Sook} and Eugene Lih and Hong, {Young Joon} and Kang, {Jong Hee} and Kim, {Ik Hwan} and Jeong, {Myung Ho} and Joung, {Yoon Ki} and Han, {Dong Keun}",
year = "2016",
month = "1",
day = "5",
doi = "10.1016/j.actbio.2016.04.029",
language = "English",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating

AU - Kim, Seong Min

AU - Park, Kwang Sook

AU - Lih, Eugene

AU - Hong, Young Joon

AU - Kang, Jong Hee

AU - Kim, Ik Hwan

AU - Jeong, Myung Ho

AU - Joung, Yoon Ki

AU - Han, Dong Keun

PY - 2016/1/5

Y1 - 2016/1/5

N2 - Stent implantation with balloon angioplasty is a widely used treatment for coronary artery diseases. Stents have been developed from bare metal stent (BMS) to advanced forms such as drug-eluting stent (DES). However, modern DES still causes thrombosis and/or in-stent restenosis as long-term outcomes. For effective prevention of these problems, we fabricated a dual functionalized stent using spatio-temporal coating, which has two different surfaces, as a novel type of DES. Hyaluronic acid conjugated with dopamine (HA-DA) was applied to a bare cobalt-chromium (CC) stent prior to abluminal coating of sirolimus (SRL)-in-polymer such as poly(d,. l-lactide). The SRL-in-polymer (P+S) coated on the abluminal surface of the HA-DA modified stent showed highly stable coating layer and prevented the crack formation after ballooning. In the blood- and cyto-compatibility tests, HA-DA coating displayed suppressive effects on adhesion and activation of platelets and maintained the cell viability and proliferation of human coronary artery endothelial cells even under the existence of SRL. In in vivo study using porcine restenosis model, the neointimal area and inflammation score of the dual functionalized stent with HA-DA and P+S were significantly reduced than those of BMS. It is expected that this novel type of DES can be effectively applied to utilize diverse anti-proliferative drugs and bioactive polymers. Statement of Significance: Stents have been developed from bare metal stent to advanced forms such as drug-eluting stents (DESs). However, even DESs can still cause in-stent restenosis as long-term outcomes. This paper demonstrated a novel DES using spatio-temporal coating by dopamine-mediated hyaluronic acid coating (HA-DA) before asymmetric coating of sirolimus-in-poly(d,. l-lactide) (P+S). It showed stable coating surface and prevented crack formation after ballooning. HA-DA coating also had an inhibitive effect on adhesion of platelets and maintained cell viability of endothelial cells even under the existence of sirolimus. Additionally, in vivo neointima area and inflammation score of HA-DA/P+S stent significantly decreased than those of BMS. We expected that this novel type of DES can be effectively applied to introduce diverse anti-proliferative drugs and bioactive molecules.

AB - Stent implantation with balloon angioplasty is a widely used treatment for coronary artery diseases. Stents have been developed from bare metal stent (BMS) to advanced forms such as drug-eluting stent (DES). However, modern DES still causes thrombosis and/or in-stent restenosis as long-term outcomes. For effective prevention of these problems, we fabricated a dual functionalized stent using spatio-temporal coating, which has two different surfaces, as a novel type of DES. Hyaluronic acid conjugated with dopamine (HA-DA) was applied to a bare cobalt-chromium (CC) stent prior to abluminal coating of sirolimus (SRL)-in-polymer such as poly(d,. l-lactide). The SRL-in-polymer (P+S) coated on the abluminal surface of the HA-DA modified stent showed highly stable coating layer and prevented the crack formation after ballooning. In the blood- and cyto-compatibility tests, HA-DA coating displayed suppressive effects on adhesion and activation of platelets and maintained the cell viability and proliferation of human coronary artery endothelial cells even under the existence of SRL. In in vivo study using porcine restenosis model, the neointimal area and inflammation score of the dual functionalized stent with HA-DA and P+S were significantly reduced than those of BMS. It is expected that this novel type of DES can be effectively applied to utilize diverse anti-proliferative drugs and bioactive polymers. Statement of Significance: Stents have been developed from bare metal stent to advanced forms such as drug-eluting stents (DESs). However, even DESs can still cause in-stent restenosis as long-term outcomes. This paper demonstrated a novel DES using spatio-temporal coating by dopamine-mediated hyaluronic acid coating (HA-DA) before asymmetric coating of sirolimus-in-poly(d,. l-lactide) (P+S). It showed stable coating surface and prevented crack formation after ballooning. HA-DA coating also had an inhibitive effect on adhesion of platelets and maintained cell viability of endothelial cells even under the existence of sirolimus. Additionally, in vivo neointima area and inflammation score of HA-DA/P+S stent significantly decreased than those of BMS. We expected that this novel type of DES can be effectively applied to introduce diverse anti-proliferative drugs and bioactive molecules.

KW - Drug-eluting stent

KW - Hyaluronic acid

KW - Restenosis

KW - Sirolimus

KW - Spatio-temporal coating

UR - http://www.scopus.com/inward/record.url?scp=84964643179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964643179&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2016.04.029

DO - 10.1016/j.actbio.2016.04.029

M3 - Article

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -